文献速递头颈介入甲状腺与浅表US

超声引导微波与射频消融治疗甲状旁腺功能亢进的系统综述与Meta分析

The Utility of Ultrasound-Guided Microwave and Radiofrequency Ablation in Primary and Secondary Hyperparathyroidism: A Systematic Review and Meta-Analysis.
PubMed 文献 · Ultrasound Med Biol · 2026-07-07

该系统综述纳入13项研究,共652例继发性(SHPT)和426例原发性甲状旁腺功能亢进(PHPT)患者。比较超声引导微波消融(MWA)、射频消融(RFA)与甲状旁腺切除术(PTX)的疗效与安全性。结果显示PTX在PHPT血钙和iPTH控制上优于热消融,但热消融在住院时间、感染率和低钙血症等方面有优势。

要点

  • PHPT中PTX降血钙和iPTH效果优于MWA及RFA,适合可手术者。
  • SHPT中RFA住院时间更短、TA感染率更低、MWA持续性低PTH更少。
  • PHPT中MWA低钙血症发生率更低,TA手术时间明显缩短。

核心结论

  • MWA和RFA可作为不适合手术的高危患者的替代治疗选择。
  • PTX仍是适合手术或病变广泛患者的首选治疗方式。

研究设计与样本

  • 系统检索Medline及六大数据库至2025年2月,纳入13项研究。
  • 纳入8项SHPT研究(652例)和5项PHPT研究(426例)。
  • 使用R统计软件进行Meta分析,比较MWA、RFA与PTX的结局。

诊断标准与关键数值

  • PHPT中PTX在3个月时血钙降低优于MWA,MD=0.06 mmol/L,95% CI [0.01, 0.10]。
  • PHPT中PTX在3个月时血钙降低优于RFA,MD=0.09 mmol/L,95% CI [0.04, 0.14]。
  • PHPT中PTX在6个月时血钙降低优于TA,MD=0.07 mmol/L,95% CI [0.03, 0.11]。
  • PHPT中PTX在3个月时iPTH降低优于TA,MD=13.49 pg/mL,95% CI [6.12, 20.86]。
  • SHPT中RFA缩短住院时间MD=-4.14,TA降低感染率RR=0.14,MWA减少持续性低PTH OR=0.02。

临床应用与阅片要点

  • 对不适合手术的高危PHPT或SHPT患者,可考虑超声引导下MWA或RFA。
  • 热消融相对PTX在住院时间、感染率和低钙血症方面具有优势。
  • ALP、磷、声音嘶哑、出血、严重低钙血症、感觉异常和复发方面两组无显著差异。

局限性

  • 纳入研究数量有限,SHPT与PHPT分别仅8项和5项。
  • 缺少ALP、磷及多项安全性指标上的显著组间差异。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE: Hyperparathyroidism is classified into primary (PHPT), secondary (SHPT) and tertiary types. While parathyroidectomy (PTX) is standard treatment, minimally invasive thermal ablation (TA) methods are increasingly being explored, especially in high-risk surgical patients. The objective of this study is to review the evidence on TA techniques, microwave (MWA) and radiofrequency (RFA), and compare them to surgical techniques in hyperparathyroidism.

METHODS: A systematic search was conducted through Medline via six major databases up to February 2025. Meta-analysis was performed using R statistical software (version 2024.04.2 Build 764).

RESULTS: Thirteen studies met the inclusion criteria (8 SHPT, 5 PHPT), involving 652 SHPT and 426 PHPT patients. In PHPT, PTX significantly reduced calcium levels mmol/L at 3 mo compared to MWA (MD = 0.06, 95% CI: [0.01, 0.10]) and RFA (MD = 0.09, 95% CI: [0.04, 0.14]); also outperforming TA at 6 mo for calcium levels mmol/L (MD = 0.07, 95% CI: [0.03, 0.11]) and at 3 mo for iPTH pg/mL (MD = 13.49, 95% CI: [6.12, 20.86]). In SHPT, RFA reduced hospital stay (MD = -4.14), TA lowered infection rates (RR = 0.14) and MWA reduced persistent low PTH (OR = 0.02). In PHPT, MWA reduced hypocalcemia (RR = 0.33), and TA shortened operation time (MD = -46.54). No significant differences were found in ALP, phosphorus, hoarseness, bleeding, severe hypocalcemia, paresthesia or recurrence (p > 0.05).

CONCLUSIONS: MWA and RFA may serve as alternatives for high-risk patients unsuitable for surgery. PTX remains the preferred option for patients with extensive disease or who are eligible for surgery.

来源:Ultrasound Med Biol,查看原文。版权归原作者所有。

引用

  1. Hindawi, Abusalah, Qafesha, et al. The Utility of Ultrasound-Guided Microwave and Radiofrequency Ablation in Primary and Secondary Hyperparathyroidism: A Systematic Review and Meta-Analysis. Ultrasound Med Biol. 2026. PMID: 42414193. doi:10.1016/j.ultrasmedbio.2026.05.025

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。